AAAAAA

   
Results: 1-10 |
Results: 10
Methodological developments for application to the study of physiological boron and to boron neutron capture therapy
Authors: Thellier, M Chevallier, A His, I Jarvis, MC Lovell, MA Ripoll, C Robertson, D Sauerwein, W Verdus, MC
Citation: M. Thellier et al., Methodological developments for application to the study of physiological boron and to boron neutron capture therapy, J TR MICROP, 19(4), 2001, pp. 623-657
A scheme for a dose-escalation study when the event is lagged
Authors: Husing, J Sauerwein, W Hideghety, K Jockel, KH
Citation: J. Husing et al., A scheme for a dose-escalation study when the event is lagged, STAT MED, 20(22), 2001, pp. 3323-3334
Transplantation of CD34-enriched peripheral stem cells from an HLA-haplotype mismatched donor to a patient with severe aplastic anemia
Authors: Kremens, B Basu, O Grosse-Wilde, H Sauerwein, W Schaefer, UW Havers, W
Citation: B. Kremens et al., Transplantation of CD34-enriched peripheral stem cells from an HLA-haplotype mismatched donor to a patient with severe aplastic anemia, BONE MAR TR, 27(1), 2001, pp. 111-113
Comparison of quality assurance for performance and safety characteristicsof the facility for Boron Neutron Capture therapy in Petten/NL with medical electron accelerators
Authors: Rassow, J Stecher-Rasmussen, F Voorbraak, W Moss, R Vroegindeweij, C Hideghety, K Sauerwein, W
Citation: J. Rassow et al., Comparison of quality assurance for performance and safety characteristicsof the facility for Boron Neutron Capture therapy in Petten/NL with medical electron accelerators, RADIOTH ONC, 59(1), 2001, pp. 99-108
Optimal detection of the neutron capture therapy agent borocaptate sodium (BSH): A comparison between H-1 and B-10 NMR
Authors: Bendel, P Sauerwein, W
Citation: P. Bendel et W. Sauerwein, Optimal detection of the neutron capture therapy agent borocaptate sodium (BSH): A comparison between H-1 and B-10 NMR, MED PHYS, 28(2), 2001, pp. 178-183
Endoluminal beta-radiation therapy for the prevention of coronary restenosis after balloon angioplasty.
Authors: Verin, V Popowski, Y de Bruyne, B Baumgart, D Sauerwein, W Lins, M Kovacs, G Thomas, M Calman, F Disco, C Serruys, PW Wijns, W
Citation: V. Verin et al., Endoluminal beta-radiation therapy for the prevention of coronary restenosis after balloon angioplasty., N ENG J MED, 344(4), 2001, pp. 243-249
Organisation and management of the first clinical trial of BNCT in Europe (EORTC protocol 11961)
Authors: Sauerwein, W Moss, R Rassow, J Stecher-Rasmussen, F Hideghety, K Wolbers, JG Sack, H
Citation: W. Sauerwein et al., Organisation and management of the first clinical trial of BNCT in Europe (EORTC protocol 11961), STRAH ONKOL, 175, 1999, pp. 108-111
Postoperative treatment of glioblastoma with BNCT at the Petten Irradiation Facility (EORTC Protocol 11961)
Authors: Hideghety, K Sauerwein, W Haselsberger, K Grochulla, F Fankhauser, H Moss, R Huiskamp, R Gabel, D de Vries, M
Citation: K. Hideghety et al., Postoperative treatment of glioblastoma with BNCT at the Petten Irradiation Facility (EORTC Protocol 11961), STRAH ONKOL, 175, 1999, pp. 111-114
Clinical implementation of neutron capture therapy
Authors: Gabel, D Pendl, G Wambersie, A Fankhauser, H Larsson, B Piscol, K",Lawazceck,"Duhmke, E Auberger, T Lemmen, P Sauerwein, W Broekart, J Bruchelt, G",Alcober,"Abbe, JC Orenstein, D Thellier, M Gibson, GAB Hopewell, J Adams, CBT East, B Loughlin, T Morris, J Kalef-Ezra, J Tavoni, R Rief, H Chiaraviglio, D Spalding, T Moss, RL Huiskamp, R Bartelink, H Voormolen, JHC Silvestre, ME Carlsson, J Salford, L Larsson, B Hiismaki, P Holsti, L Zsolnay, EM Ebulska-Wasilewska, AC Litvchenko, P Murzin, A
Citation: D. Gabel et al., Clinical implementation of neutron capture therapy, BIOM HLTH R, 24, 1998, pp. 282-287
Glioma treatment with BNCT
Authors: Gabel, D Moss, RL Pendl, G Sauerwein, W Fankhauser, H Heimans, J Stecher-Resmussen, F Piscol, K Reulen, HJ Pignol, JP
Citation: D. Gabel et al., Glioma treatment with BNCT, BIOM HLTH R, 24, 1998, pp. 288-293
Risultati: 1-10 |